Patents by Inventor Richard William Falla Le Page

Richard William Falla Le Page has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids and proteins from
    Patent number: 8632784
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: January 21, 2014
    Assignee: Sanofi Pasteur Limited
    Inventors: Richard William Falla Le Page, Jeremy Mark Wells, Sean Bosco Hanniffy, Philip Michael Hansbro
  • Secreted proteins
    Patent number: 8101187
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: January 24, 2012
    Assignee: Sanofi Pasteur Limited
    Inventors: Richard William Falla Le Page, Daniel Badcock, Philip James Holden Sizer, Keith Peek, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Secreted Streptococcus Pneumoniae Proteins
    Publication number: 20090074808
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Application
    Filed: July 28, 2008
    Publication date: March 19, 2009
    Inventors: Richard William Falla Le Page, Daniel Badcock, Philip James Holden Sizer, Keith Peek, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Nucleic acids and proteins from group B streptococcus
    Patent number: 7098182
    Abstract: Novel protein antigens from Group B Streptococcus are described, together with nucleic acid sequences encoding them. Their use in vaccines and screening methods is also described.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: August 29, 2006
    Assignee: Microbial Technics Limited
    Inventors: Richard William Falla Le Page, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Proteins
    Publication number: 20040265933
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Application
    Filed: August 30, 2004
    Publication date: December 30, 2004
    Inventors: Richard William Falla Le Page, Daniel Badcock, Philip James Holden Sizer, Keith Peek, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Delivery of biologically active polypeptides
    Publication number: 20030202991
    Abstract: Biologically active polypeptides and/or antigens are delivered by administering to a subject a non-invasive or non-pathogenic bacterium which expresses one or more antigens or polypeptides. The non-invasive or non-pathogenic bacterium can be included in delivery systems or pharmaceutical formulations.
    Type: Application
    Filed: January 22, 2003
    Publication date: October 30, 2003
    Inventors: Lothar Steidler, Erik Remaut, Jeremy Mark Wells, Richard William Falla Le Page
  • Proteins
    Publication number: 20030170782
    Abstract: Novel protein antigens from Group B Streptococcus are described, together with the nucleic acid sequences encoding them. The use of vaccines and screening methods is also described.
    Type: Application
    Filed: March 6, 2002
    Publication date: September 11, 2003
    Inventors: Richard William Falla Le Page, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Delivery of biologically active polypeptides
    Patent number: 6605286
    Abstract: Biologically active polypeptides and/or antigens are delivered by administering to a subject a non-invasive or non-pathogenic bacterium which expresses one or more antigens or polypeptides. The non-invasive or non-pathogenic bacterium can be included in delivery systems or pharmaceutical formulations.
    Type: Grant
    Filed: April 16, 1998
    Date of Patent: August 12, 2003
    Assignees: Vlaams Interuniversitair Instituut voor Biotechnologie, Microbial Technics Limited
    Inventors: Lothar Steidler, Erik Remaut, Jeremy Mark Wells, Richard William Falla Le Page
  • Nucleic acids and proteins from group B streptococcus
    Publication number: 20030138775
    Abstract: Novel protein antigens from Group B Streptococcus are described, together with nucleic acid sequences encoding them. Their use in vaccines and screening methods is also described.
    Type: Application
    Filed: January 26, 2001
    Publication date: July 24, 2003
    Inventors: Richard William Falla Le Page, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Nucleic acids and proteins from Streptococcus pneumoniae
    Publication number: 20030134407
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Application
    Filed: January 26, 2001
    Publication date: July 17, 2003
    Inventors: Richard William Falla Le Page, Jeremy Mark Wells, Sean Bosco Hanniffy, Philip Michael Hansbro
  • DELIVERY OF BIOLOGICALLY ACTIVE POLYPEPTIDES
    Publication number: 20010006642
    Abstract: Methods of delivering biologically active polypeptides and/or antigens by administering to a subject a non-invasive or non-pathogenic bacterium which expresses the one or more antigens or polypeptides. Also, nucleic acids, delivery systems, pharmaceutical formulations comprising such delivery systems and methods of making same.
    Type: Application
    Filed: April 16, 1998
    Publication date: July 5, 2001
    Inventors: LOTHAR STEIDLER, ERIK REMAUT, JEREMY MARK WELLS, RICHARD WILLIAM FALLA LE PAGE
  • Heterologous gene expression in lactococcus, and the expression products therefrom
    Patent number: 6221648
    Abstract: Heterologous polypeptides are produced in lactococcus using a T7 or T7-like RNA polymerase gene under the control of an inducible promoter effective in a lactococcus host, and a promoter specific for said polymerase upstream of a coding sequence for the heterologous polypeptide. Thus, the promoter specific for the polymerase directs transcription of the coding sequence selectively as a result of expression of the polymerase. The heterologous polypeptide can be produced at high yield, and can be secreted. The polypeptide within the cell, being biologically active, can be delivered in the encapsulated form, e.g. as a medicament, vaccine or as an environmental pesticide.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: April 24, 2001
    Assignee: Microdial Technics Ltd.
    Inventors: Richard William Falla Le Page, Jeremy Mark Wells, Peter William Wilson, Pamela Norton De Villareal